Summit Wealth Group (Colorado)’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$481K Sell
3,904
-159
-4% -$19.8K 0.03% 270
2026
Q2
$481K Sell
4,063
-201
-5% -$21.8K 0.04% 221
2026
Q1
$442K Buy
4,264
+9
+0.2% +$951 0.05% 196
2025
Q4
$445K Buy
+4,255
New +$428K 0.06% 158
2025
Q3
– Sell
-4,582
Closed -$366K – 591
2025
Q2
$366K Buy
+4,582
New +$366K 0.09% 161

Other funds holding PJP

Summit Wealth Group (Colorado)'s PJP Position: Q3 2026 in Review

Summit Wealth Group (Colorado) reduced its Invesco Pharmaceuticals ETF (PJP) stake by 3.9% in Q3 2026, selling an estimated $19.8K and leaving 3,904 shares worth $481K. The position accounts for 0.03% of the portfolio, ranked #270.

Summit Wealth Group (Colorado) first reported a position in PJP in Q2 2025 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Summit Wealth Group (Colorado) held 3,904 shares of Invesco Pharmaceuticals ETF worth $481K as of Q3 2026.
  • Summit Wealth Group (Colorado) sold 159 Invesco Pharmaceuticals ETF shares in Q3 2026, an estimated $19.8K.
  • Invesco Pharmaceuticals ETF made up 0.03% of Summit Wealth Group (Colorado)'s portfolio in Q3 2026, its #270 holding.
  • Summit Wealth Group (Colorado) first reported a position in Invesco Pharmaceuticals ETF in Q2 2025 and has held it in 5 quarters since.
  • 135 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q3 2026, filed 29 Oct 2026.